High doses of intravenous recombinant erythropoietin for the treatment of anaemia in myelodysplastic syndrome
- 1 June 1993
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 84 (2) , 232-237
- https://doi.org/10.1111/j.1365-2141.1993.tb03057.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: A clinical and erythrokinetic assessmentAnnals of Hematology, 1992
- Treatment of myelodysplastic syndromesBlood Reviews, 1991
- The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietinBritish Journal of Haematology, 1991
- Responsiveness of bone marrow erythropoietic stem cells (CFU‐E and BFU‐E) to recombinant human erythropoietin (rh‐Ep) in vitro in aplastic anemia and myelodysplastic syndromeAmerican Journal of Hematology, 1990
- Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritisThe American Journal of Medicine, 1990
- Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemiaThe International Journal of Cell Cloning, 1990
- Treatment of Myelodysplastic Syndromes with Recombinant Human Granulocyte Colony-Stimulating FactorAnnals of Internal Medicine, 1989
- Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: Clinical and in vitro studiesArthritis & Rheumatism, 1989
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982